Status:
UNKNOWN
Research of Automated Maculopathy Screening Based on AI Techniques Using OCT Images
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Maculopathy
Eligibility:
All Genders
Brief Summary
The investigators expect to develop an algorithm that can interpret OCT images and automated determine whether the macula is normal or not by using OCT image-based deep learning techniques. And invest...
Detailed Description
The investigators will apply deep learning convolutional neural network by using ImageNet for an automated detection of multiple retinal diseases with OCT horizontal B-scans with a high-quality labele...
Eligibility Criteria
Inclusion
- All patients attending the Ophthalmology Department of the First Affiliated Hospital of Nanjing Medical University within 5 years and who received known, clear diagnoses with digital retinal imaging (including OCT, fundus digital photographs and fundus fluorescein angiography, at least with OCT images) as part of their routine clinical care, will be eligible for inclusion in this study.
Exclusion
- Hardcopy examinations (i.e., photos of paper reports of OCT imaging performed at other hospitals) will be ineligible.
- Data from patients who have previously manually requested that their data should not be shared, even for research purposes in anonymised form, and have informed the Ophthalmology Department of the First Affiliated Hospital of Nanjing Medical University of this desire (even in previously conducted studies or other on-going studies in this hospital), will be excluded, and their data will not be upload to the cloud platform before research begins.
- Data from eyes tamponed with silicone oil or gas (i.e., C3F8) will be ineligible.
- Data with poor image quality, such as incomplete images, inverted images, blurred or cracked images and images with a very weak signal (i.e., vitreous haemorrhage), will be ineligible.
Key Trial Info
Start Date :
June 30 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT03476291
Start Date
June 30 2017
End Date
December 31 2020
Last Update
March 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China, 210029